Introduction
Recombinant Human PSMD13 (proteasome 26S subunit, non-ATPase 13) is a protein that plays a crucial role in the regulation of protein degradation in eukaryotic cells. It is a subunit of the 26S proteasome, a multi-protein complex responsible for the degradation of damaged or unwanted proteins. In this article, we will discuss the structure, activity, and potential applications of recombinant human PSMD13.
Structure of Recombinant Human PSMD13
The human PSMD13 gene is located on chromosome 7 and encodes for a protein of 364 amino acids. The recombinant form of PSMD13 is produced through genetic engineering techniques, where the gene is inserted into a host cell, such as E. coli, and expressed to produce large quantities of the protein.
The crystal structure of PSMD13 has been determined, revealing that it is composed of two domains: an N-terminal domain and a C-terminal domain. The N-terminal domain contains a ubiquitin-like (UBL) domain, while the C-terminal domain contains a proteasome-activating motif (PAM) that is responsible for the interaction with other subunits of the 26S proteasome complex.
Activity of Recombinant Human PSMD13
Recombinant human PSMD13 is involved in the assembly and activation of the 26S proteasome complex. The UBL domain of PSMD13 binds to the Rpn10 subunit of the 19S regulatory particle, while the PAM domain interacts with the Rpn1 subunit. This interaction is crucial for the recruitment of the 19S regulatory particle to the 20S core particle, forming the fully functional 26S proteasome complex.
The 26S proteasome complex is responsible for the degradation of proteins that are marked for destruction by the attachment of ubiquitin molecules. PSMD13 plays a critical role in this process by recognizing and binding to the ubiquitin chains, allowing for the efficient degradation of the targeted proteins.
Applications of Recombinant Human PSMD13
Recombinant human PSMD13 has a wide range of potential applications in both basic research and therapeutic development. Some of its potential applications include:
1. Studying the Proteasome Pathway
By using recombinant human PSMD13, researchers can study the role of this protein in the assembly and activation of the 26S proteasome complex. This can provide insights into the mechanisms of protein degradation and its implications in various cellular processes.
2. Drug Target Identification
The proteasome pathway has been identified as a potential target for the development of drugs for the treatment of various diseases, including cancer. Recombinant human PSMD13 can be used in drug screening assays to identify compounds that can disrupt the assembly or activity of the 26S proteasome complex, providing potential leads for drug development.
3. Therapeutic Applications
Recombinant human PSMD13 has also been investigated as a potential therapeutic target for the treatment of diseases characterized by abnormal protein degradation, such as neurodegenerative diseases. By targeting PSMD13, researchers hope to modulate the activity of the proteasome pathway and potentially slow down the progression of these diseases.
4. Diagnostic Tool
Studies have shown that the expression of PSMD13 is altered in various types of cancer, making it a potential diagnostic marker for these diseases. Recombinant human PSMD13 can be used to develop diagnostic assays for the early detection of cancer and monitoring of treatment response.
Conclusion
In summary, recombinant human PSMD13 is a vital protein involved in the assembly and activation of the 26
There are no reviews yet.